News

FDA approved the first biosimilar to Neulasta, as well as a new combination treatment for osteoarthritis pain and hypertension and a new drug to treat chronic lymphocytic leukemia.

The manufacturer of two cancer drugs hiked the price on the medicines despite President Donald Trump’s new plan to lower drug prices.

Virtually all healthcare leaders recognize the value of content creation, yet the use of a well-defined content strategy is rare. Here’s how to get yours.

A Quest Diagnostics study sheds light on Medicare patients with multiple chronic conditions and the top three care gaps.

Rapid advances in the availability of big data and in machine learning offer significant opportunities to improve the healthcare system.

A study evaluated how treating military veterans with HCV early impacted their risk for non-Hodgkin lymphoma and various other diseases.

A study of Medicaid and Medicare Advantage plan members shows that addressing social determinants of health is important not only to reduce health spending, but also to improve patient outcomes.

Treating patients with cancer is often challenging yet rewarding work. But caring for patients in an urban setting, where some patients don’t speak English and other patients aren’t fully insured and possibly facing significant financial challenges.

Montefiore Medical Center in Bronx, New York, is participating in CMS’ oncology care model, a value-based payment arrangement. Find out what new group of staff members is helping it succeed.

Analysis from Avalere shows why healthcare execs should understand how oncology practices are evolving in response to the OCM.

FDA is warning that 2 liquid-filled intragastric balloon systems used to treat obesity are causing deaths in some patients

FDA’s new guidances on Risk Evaluation and Mitigation Strategy (REMS) requirements aims to help generic and biosimilar drugs get to market faster.

A survey from EY reveals how consumers use technology and how to mix engagement tools and existing EHR features.

Using EHRs and other technologies can enhance care coordination, patient engagement.

Many healthcare organizations are expanding leadership roles to help meet business and patient-centered goals.

A Canadian study has exciting findings about offspring exposed to tumor necrosis factors.

Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.

Experts say Anthem’s acquisition of Aspire Health, the nation’s biggest non-hospice, community-based palliative care provider, continues the health insurer race to dominate this kind of health experience.

In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers-but is it also good news for MCOs?

A network of value-based care programs from the Blue Cross Blue Shield Association emphasizes quality instead of quantity of medical services provided.

Major depression diagnoses have risen, according to a study of medical claims by the Blue Cross Blue Shield Association. Find out which populations suffer the most.

For far too long, chart chasing was the best method health plans had to improve HEDIS® measures and Medicare Star ratings. Now, there is a better way.

We’ve detailed 10 proven ways all health plans can put into practice now to improve scores this HEDIS® season.

Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.